Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company: Theranexus & Pherecydes-Pharma POCs
  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems was invited at the France-India healthcare Summit to present its Computer Augmented Deductive Intelligence platform and its operational successes

  • PRESS-RELEASE: Discover why and how CEOs and R&D managers have already launched “Fully External B plans” to de-risk their businesses and generate unexpected opportunities.

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems invited to present its collaborative success story with CEA life Sciences at the 10 years anniversary of Medicen Paris Region Health cluster

  • 2017: Happy New Year: Our 8 Resolutions for 2017 to be ready for the upcoming bubble explosion! - Bonne Année: Nos 8 Résolutions pour 2017
     
  • 2016: INTERVIEW (Post LinkedIn FR avec explications): "Drug Discovery and health Big Data. The enormous Bubble will explode.” (Post LinkedIn ENG with all the explanations)  Manuel GEA, CEO of BMSystems in Biotech & Finances the leading biotech sector information letter

  • 2016: PRESS-RELEASE: Paris October 4, 2016: Theranexus, a CEA Life Sciences' spin-off exploiting CEA/BMSystems' copatent WO/2010/029131, obtained an orphan drug designation from the FDA for THN102, (in Phase II)  in the treatment of narcolepsy. Download  the official Theranexus' press-relase

  • 2016: ANNOUNCEMENT: Paris October 5, 2016: BMSystems' CEO invited to present its digital-biology strategy and achievements at the inaugural session of Medicen Paris Region 10th years anniversary

  • 2016: PRESS RELEASE: Paris September 5, 2016: BMSystems selected to present CADI Discovery at the Connexion R&D conference organized by COSMETIC-VALLEY the leading Perfumery & Cosmetic cluster in France.

  • 2016: ANNOUNCEMENT August 1, 2016: BIO-MODELING SYSTEMS' novel Parkinson's therapy mentioned in a Report Covering 179 Companies. A new recognition of CADI Discovery capability to generate novel therapeutic strategies in complex human diseases of which CNS
     
  • 2016: ANNOUNCEMENT : May 31, 2016: Theranexus, CEA Life Sciences' spin-off exploiting CEA/BMSystems' copatent WO/2010/029131, in CNS therapies in Biotech Info (page 11)

  • 2016: Updated: Inaugural Presentation Bio-Entrepreneur 2015: The future will be digital and biology, but who will lead? Google? Watson? Alone or MDs, Physiologists, Biologists educating and mastering them combining diagnostics, therapies, connected devices and IT technologies?

Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology company that delivers

"Correct understanding of life mechanisms makes novel integrated diagnostics, therapies & preventive solutions discovery smarter, faster & cheaper for healthcare, diagnostic, health technologies, nutrition, and cosmetics!"

Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADI™* models.

Created in 2004, profitable since 2006, thanks to our recurrent clients, our robust decision-making support & discoveries already led to:

  1. A world's first in neurodegenerative diseases (publication) with CEA: 2 awards in the US & Europe.

  2. Pherecydes-Pharma: BMSystems' spin-off, MR infections therapies,  3 patents, publication, world's first clinical multi-centric trial with bacteriophages in Phase I/II,

  3. Theranexus: the CEA Life Sciences' spin-off exploiting  CEA/BMSystems' copatent  WO/2010/029131, in CNS therapies,  Phase II entry,  ODD from FDA, and

  4. Our high impact "robust decision-making"support, to answer the unacceptable clinical failure rate of 90%-95% for CEOs, R&D, Business Managers  & Investors.

  5. Our Digital R&D, and E health "transformation" expertise to help and support our clients/partners to understand the real potential and limits of the digital giants promises in discovery and implement with the expected ROI their programs with the right concepts and tools.   

We warmly invite you to download our  6 pages management summary,  our Short corporate Presentation or our Full Presentation with all non-confidential details of our 10 POCs.
 

The life-modeling issue

 

BMSystems’ solutions to critical & high impact R&D and business issues

Invented and operated by our Biologists, CADI™* Discovery is, since 2004, the world's first and only to date operational "Mechanisms-based Medicine" platform that proposes:

  1. robust decision making support for R&D and Business, and

  2. the discovery of cost-effective lower risk patentable novel integrated solutions,
     

*CADI™ : Computer Assisted Deductive Integration based on non-invasive Computer Augmented Deductive Intelligence concepts and tools